New Research Reveals Unique Microbial Characteristics in Ulcerative Colitis and Crohn’s Disease
geralt / Pixabay

New Research Reveals Unique Microbial Characteristics in Ulcerative Colitis and Crohn’s Disease

According to a story from news-medical.net, a team of researchers have found that patients with inflammatory bowel disease display distinct changes to the makeup of bacteria that live in their…

Continue Reading New Research Reveals Unique Microbial Characteristics in Ulcerative Colitis and Crohn’s Disease
Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?
source: pixabay.com

Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?

What is the Disparity? America is greatly divided by many things and race has always been one of them. Not only are there large social and economic divides among racial…

Continue Reading Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?

Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases

Xconomy.com has just released that funds have been raised for a variety of companies investigating therapies for rare conditions. Unfortunately, novel therapies and inventions cost million of dollars to develop. Thankfully,…

Continue Reading Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases
A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!
source: pixabay.com

A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!

Myelodysplastic syndromes (MDS) is the name used to describe a group of stem cell disorders in which the body can't produce an adequate amount of platelets and blood cells. Currently,…

Continue Reading A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!
New Combination Therapy for Renal Cell Carcinoma Gains European Approval
source: pixabay.com

New Combination Therapy for Renal Cell Carcinoma Gains European Approval

According to a story from BioPortfolio, the Bristol-Myers Squibb Company recently announced that the European Commission has recently approved the first combination treatment for renal cell carcinoma available in the…

Continue Reading New Combination Therapy for Renal Cell Carcinoma Gains European Approval